loadpatents
name:-0.017241954803467
name:-0.0073251724243164
name:-0.0024669170379639
Erb; Klaus Patent Filings

Erb; Klaus

Patent Applications and Registrations

Patent applications and USPTO patent grants for Erb; Klaus.The latest application filed is for "polypeptides comprising immunoglobulin single variable domains targeting il-13 and tslp".

Company Profile
1.7.18
  • Erb; Klaus - Ingelheim Am Rhein DE
  • ERB; Klaus - Mittelbiberach DE
  • Erb; Klaus - Goslar DE
  • Erb, Klaus - Wurzburg DE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Tslp
App 20220177565 - Rommelaere; Heidi ;   et al.
2022-06-09
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Tslp
App 20220177564 - Rommelaere; Heidi ;   et al.
2022-06-09
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Tslp
App 20220177566 - Rommelaere; Heidi ;   et al.
2022-06-09
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Ox40l
App 20220153854 - Rommelaere; Heidi ;   et al.
2022-05-19
Polypeptides comprising immunoglobulin single variable domains targeting IL-13 and TSLP
Grant 11,208,476 - Rommelaere , et al. December 28, 2
2021-12-28
Recombinant rhabdovirus encoding for a CD80 extracellular domain Fc-fusion protein
App 20210379130 - MUELLER; Philipp ;   et al.
2021-12-09
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Tslp
App 20210214431 - Rommelaere; Heidi ;   et al.
2021-07-15
Polypeptides Comprising Immunoglobulin Single Variable Domains Targeting Il-13 And Tslp
App 20210188965 - Rommelaere; Heidi ;   et al.
2021-06-24
Recombinant Rhabdovirus Encoding For Ccl21
App 20200237838 - MUELLER; Philipp ;   et al.
2020-07-30
Thiazolyl-dihydro-quinazolines
Grant 8,354,418 - Brandl , et al. January 15, 2
2013-01-15
Thiazolyl-dihydro-quinazoline compounds and processes for preparing same
Grant 8,334,378 - Brandl , et al. December 18, 2
2012-12-18
Thiazolyl-dihydro-quinazoline compounds and processes for preparing same
App 20100145041 - BRANDL; Trixi ;   et al.
2010-06-10
Thiazolyl-dihydro-quinazoline
Grant 7,691,868 - Brandl , et al. April 6, 2
2010-04-06
Thiazolyl-dihydro-chinazoline
App 20090131424 - BRANDL; Trixi ;   et al.
2009-05-21
Thiazolyl-dihydro-cyclopentapyrazole
Grant 7,517,995 - Breitfelder , et al. April 14, 2
2009-04-14
Thiazolyl-dihydro-indazole
App 20090093474 - Grauert; Matthias ;   et al.
2009-04-09
Process for the continuous recovery of free tartaric acid from raw materials containing potassium hydrogentartrate
Grant 7,311,837 - Stein , et al. December 25, 2
2007-12-25
Thiazolyl-dihydro-indazole
App 20070259855 - Maier; Udo ;   et al.
2007-11-08
Thiazolyl-dihydro-quinazoline
App 20070244104 - Brandl; Trixi ;   et al.
2007-10-18
Thiazolyl-dihydro-indazole
App 20070238718 - GRAUERT; Matthias ;   et al.
2007-10-11
Thiazolyl-dihydro-cyclopentapyrazole
App 20070238730 - Breitfelder; Steffen ;   et al.
2007-10-11
Thiazolyl-dihydro-chinazoline
App 20070238746 - Brandl; Trixi ;   et al.
2007-10-11
Process for the continuous recovery of free tartaric acid from raw materials containing potassium hydrogentartrate
App 20040232078 - Stein, Dieter ;   et al.
2004-11-25
Method of using a vaccine
App 20030138436 - Le Gros, Graham Stephen ;   et al.
2003-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed